Although anti-PD-1 therapy combined with chemotherapy in GTN has been reported to have shown improved antitumor effects and tolerable toxic effects, the immunotherapy used was camrelizumab (PD-1 inhibitor) combined with apatinib.48 The gene discussed is PDCD1; the disease is gestational trophoblastic neoplasm.